Beecham Group Plc &lt;BHAM.L> said itssubsidiary &lt;Beecham Pharmaceuticals> launched a new once-a-day,prescription only medicine for the reduction of pain andinflammation caused by rheumatoid and osteoarthritis. Thelaunch took place simultaneously in the U.K. And West Germany.    The drug, which has the approved name Nabumetone, will beintroduced to doctors in the U.K. Under the brand name ofRelifex and will be known as Arthaxan in West Germany. REUTER&#3;